C

CenExel Clinical Research | Anaheim Clinical Trials

Research site
(Unclaimed)
Location
2441 W La Palma Avenue, Suite 140, Anaheim, California, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

14 of 196
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) (ROCKET-Ignite)

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participa...

Enrolling
Celiac Disease
Drug: Cohort 2 in Part A
Drug: Group 4 in Part B and Part C

The objective of this study is to assess the bioavailability of risankizumab liquid vial manufactured with the new process (CMC3) relative to the cur...

Active, not recruiting
Healthy Volunteers
Drug: Risankizumab

The purpose of this study is to assess the safety, tolerability, and single-dose pharmacokinetics of danicamtiv in healthy Japanese and Caucasian par...

Enrolling
Healthy Volunteers
Drug: Placebo
Drug: Danicamtiv

The purpose of the study is to learn about the safety of PF-07817883 and how PF-07817883 is processed in the body of adult participants. These partic...

Enrolling
COVID-19
Drug: PF-07817883

The purpose of the study is to learn how the study medicine called PF-07868489 is tolerated and acts in healthy adult people and people with pulmonar...

Enrolling
Pulmonary Arterial Hypertension
Drug: Placebo for PF-07868489
Drug: PF-07868489
Locations recently updated

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple escalating oral doses o...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Obesity
Drug: Placebo
Drug: Midazolam

The purpose of this study is to compare two finished products of PF-07940367 in terms of the uptake into the blood stream.This study is seeking parti...

Enrolling
Healthy
Drug: PF-07940367

The primary objective of this study is to evaluate the analgesic efficacy of DMTS, compared with placebo, in subjects following abdominoplasty.

Enrolling
Pain, Postoperative
Drug: Placebo Patch
Drug: DMTS Patch

This study will evaluate safety, tolerability, pharmacokinetic (PK) profile, and pharmacodynamic (PD) effects on GSBR-1290 in healthy overweight/obes...

Active, not recruiting
Overweight or Obesity
Type2 Diabetes Mellitus
Drug: GSBR-1290
Drug: Placebo

The main objective of this study is to assess pharmacokinetics, safety, and tolerability of ABBV-932 in healthy adult participants.

Enrolling
Healthy Participants
Generalized Anxiety Disorder (GAD)
Drug: Placebo
Drug: ABBV-932

The purpose of the study is to learn how different forms of a study medication called danuglipron are taken into the blood in healthy adults.

Enrolling
Healthy Participants
Healthy Subjects
Drug: Formulation C
Drug: Formulation B

An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody response of a vaccine to prevent s...

Active, not recruiting
Clostridoides Difficile Associated Disease
Biological: C. difficile vaccine formulation 1.
Biological: C. difficile vaccine formulation 2.

Trial conditions

Psoriasis (17 trials)
Diabetes Mellitus (16 trials)
Type 2 Diabetes Mellitus (16 trials)
Postoperative Pain (12 trials)
Obesity (11 trials)
COVID-19 (8 trials)
Human Influenza (7 trials)
Acute Pain (6 trials)
Migraine Disorders (6 trials)
Colitis (5 trials)

And 62 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems